Categories: NewsNutrition

Better Choice Company Reports Record Second Quarter 2022 Gross Sales and Provides Corporate Update

  • Better Choice Reports Record Second Quarter 2022 Gross Sales of $19.8 Million and Net Sales of $16.5 Million, Representing a Quarter-Over-Quarter Increase in Net Sales of 50%, Driven by 133% Increase in Brick & Mortar Sales and 75% Increase in International Sales.
  • Better Choice Reports Record First Half 2022 Gross Sales of $39.5 Million and Net Sales of $33.5 million, representing a Year-Over-Year Increase in Net Sales of 54%.
  • Better Choice Reports Second Quarter Gross Margin of 29% and Adjusted Gross Margin of 31%, Representing an Increase from First Quarter 2022 Gross Margin of 28%.
  • Better Choice Believes Second Quarter 2022 Cash Balance of $17.8 million is Sufficient to Support Plan to Achieve Profitability and Expects Positive Changes to Net Working Capital Position in 2H 2022.

NEW YORK, Aug. 11, 2022 (GLOBE NEWSWIRE) — Better Choice Company Inc. (NYSE American: BTTR) (the “Company” or “Better Choice”), a pet health and wellness company, today reported its financial results for the second quarter ended June 30, 2022.

“In spite of unprecedented supply chain disruptions felt across the consumer-packaged goods industry, during the second quarter of 2022 we were able to deliver sequential adjusted gross margin improvement of approximately 300 basis points and 50% growth in net sales relative to the second quarter of 2021, driven by growth of 75% in International sales and 133% in Brick & Mortar sales. The $19.8 million of gross sales generated in this quarter represents an all-time high for Better Choice, surpassing the $19.7 million generated in the first quarter of 2022. While our International business continues to grow rapidly, we are making great progress in pet specialty. We have already launched Halo Elevate® in over 1,500 pet specialty stores including Petco, Pet Supplies Plus and key independent retailers, and have observed consistent week-over-week growth of POS sales, coupled with strong repeat customer purchase rates at key accounts,” said Scott Lerner, CEO of Better Choice.

“In addition to delivering record gross sales, we also realized meaningful sequential gross margin improvement, achieving a gross margin of 29% in Q2 2022 vs. 28% in Q1 2022. Adjusting for one-time pet specialty launch expenses, we achieved an adjusted gross margin of 31% in Q2 2022. This improvement in Q2 2022 was driven by several key factors, including the shift of domestic kibble production to a new co-manufacturer, the consolidation of production runs across our portfolio and the implementation of domestic and international price increases. In the second half of 2022 we expect to realize continued gross margin improvements, driven primarily by the transition of our international dry kibble diets to a new co-manufacturer. This transition was completed in mid-June and resulted in an immediate 1,500 to 2,000 basis point improvement to gross margin. Prior to the transition, these diets represented approximately $10 million of net sales in the first half of 2022. We also have a lot of exciting new developments planned, including the continued distribution of Halo Elevate® nationwide and the rebrand of Halo Holistic™ and Trudog. We believe our second quarter cash position is sufficient to support our plan to achieve profitability, particularly since we expect to benefit from positive changes to net working capital in the second half of 2022. While we are very excited by our sales growth in the first half of this year, we remain laser focused on driving continued margin improvements across our portfolio,” concluded Mr. Lerner.

Second Quarter 2022 and Subsequent Operational Updates

  • Launched Halo Elevate® in 1,000+ Petco retail locations.
  • Launched Halo Elevate® in 600+ Pet Supplies Plus retail locations.
  • Launched global marketing campaign to coincide with pet specialty launch, generating more than 42 million impressions and 22 million video views in the first six weeks post-launch.
  • Completed co-manufacturing transition of key international diets in mid-June, resulting in an immediate 1,500 to 2,000 basis point gross margin improvement for these diets. Prior to the transition, these diets represented approximately $10 million of net sales in the first half of 2022 (approximately 70% of total international net sales).
  • Completed integration of TruDog Brand and launched Halo® branded freeze-dried raw meals, treats and toppers.
  • Implemented Domestic and International price increases effective April 2022 to address inflationary pressures.

Second Quarter 2022 Corporate Updates

  • Promoted Robert Sauermann to Chief Operating Officer and Donald Young to Chief Sales Officer.
  • Certain members of the Board of Directors and Management team purchased 566,269 common shares led by Donald Young, representing approximately 2% of the basic common shares outstanding.
  • Joined the Russell Microcap® Index, effective June 27, 2022.

Conference Call and Webcast Information

The Company will host a conference call and audio webcast on Thursday, August 11, 2022 at 8:30 am (Eastern Time) to answer questions about the Company’s operational and financial highlights for the second quarter of 2022.

Event: Better Choice Second Quarter 2022 Earnings Call
Date: Thursday, August 11, 2022
Time: 8:30 a.m. Eastern Time
Live Call: +1-844-825-9789 (U.S. Toll-Free) or +1-412-317-5180 (International)
Webcast: https://viavid.webcasts.com/starthere.jsp?ei=1561045&tp_key=cb321c959e

For interested individuals unable to join the conference call, a dial-in replay of the call will be available until August 25, 2022 and can be accessed by dialing +1-844-512-2921 (U.S. Toll Free) or +1-412-317-6671 (International) and entering replay pin number: 10169599.

Better Choice Company Inc.
Unaudited Consolidated Statements of Operations
(Dollars in thousands, except share and per share amounts)

    Three Months Ended
June 30,
  Six Months Ended
June 30,
      2022       2021       2022       2021  
Net sales   $ 16,515     $ 10,989     $ 33,529     $ 21,819  
Cost of goods sold     11,788       7,088       24,095       13,644  
Gross profit     4,727       3,901       9,434       8,175  
Operating expenses:                
Selling, general and administrative     8,187       6,766       15,764       13,653  
Share-based compensation     801       332       1,892       2,857  
Total operating expenses     8,988       7,098       17,656       16,510  
Loss from operations     (4,261 )     (3,197 )     (8,222 )     (8,335 )
Other (expense) income:                
Interest expense, net     (106 )     (2,234 )     (182 )     (3,069 )
Gain on extinguishment of debt, net           851             457  
Change in fair value of warrant liabilities           29,356             22,873  
Total other (expense) income, net     (106 )     27,973       (182 )     20,261  
Net (loss) income before income taxes     (4,367 )     24,776       (8,404 )     11,926  
Income tax expense                 3        
Net (loss) income available to common stockholders   $ (4,367 )   $ 24,776     $ (8,407 )   $ 11,926  
                 
Weighted average number of shares outstanding, basic     29,364,712       11,126,909       29,327,316       10,361,462  
Weighted average number of shares outstanding, diluted     29,364,712       21,389,413       29,327,316       20,498,829  
Net (loss) income per share available to common stockholders, basic   $ (0.15 )   $ 2.23     $ (0.29 )   $ 1.11  
Net (loss) income per share available to common stockholders, diluted   $ (0.15 )   $ 1.19     $ (0.29 )   $ 0.56  
                                 
                                 

Better Choice Company Inc.
Unaudited Condensed Consolidated Balance Sheets
(Dollars in thousands, except share and per share amounts)

    June 30, 2022   December 31, 2021
Assets        
Cash and cash equivalents   $ 10,860     $ 21,729  
Restricted cash     6,963       7,213  
Accounts receivable, net     8,691       6,792  
Inventories, net     10,489       5,245  
Prepaid expenses and other current assets     2,948       2,940  
Total Current Assets     39,951       43,919  
Fixed assets, net     480       369  
Right-of-use assets, operating lease     31       56  
Intangible assets, net     10,823       11,586  
Goodwill     18,614       18,614  
Other assets     101       116  
Total Assets   $ 70,000     $ 74,660  
Liabilities & Stockholders’ Equity        
Current Liabilities        
Accounts payable   $ 4,004     $ 4,553  
Accrued and other liabilities     2,215       1,879  
Term loan, net     1,130       855  
Operating lease liability     33       54  
Total Current Liabilities     7,382       7,341  
Non-current Liabilities        
Term loan, net     3,866       4,559  
Line of credit, net     7,368       4,856  
Deferred tax liability     24       24  
Operating lease liability           5  
Total Non-current Liabilities     11,258       9,444  
Total Liabilities     18,640       16,785  
Stockholders’ Equity        
Common Stock, $0.001 par value, 200,000,000 shares authorized, 29,364,712 and 29,146,367 shares issued and outstanding as of June 30, 2022 and December 31, 2021, respectively     29       29  
Series F Preferred Stock, $0.001 par value, 30,000 shares authorized, 0 shares issued and outstanding as of June 30, 2022 and December 31, 2021, respectively            
Additional paid-in capital     318,994       317,102  
Accumulated deficit     (267,663 )     (259,256 )
Total Stockholders’ Equity     51,360       57,875  
Total Liabilities and Stockholders’ Equity   $ 70,000     $ 74,660  


Better Choice Company Inc.
Non-GAAP Measures
(Dollars in thousands)

Adjusted EBITDA

Better Choice Company defines Adjusted EBITDA as EBITDA further adjusted to eliminate the impact of certain items that we do not consider indicative of our core operations. Adjusted EBITDA is determined by adding the following items to net (loss) income: interest expense, tax expense, depreciation and amortization, share-based compensation, warrant expense, loss on disposal of assets, change in fair value of warrant liabilities, gain or loss on extinguishment of debt, equity and debt offering expenses and other non-recurring expenses.

The Company presents Adjusted EBITDA as it is a key measure used by our management and board of directors to evaluate our operating performance, generate future operating plans and make strategic decisions regarding the allocation of capital. We believe that the disclosure of Adjusted EBITDA is useful to investors as this non-GAAP measure forms the basis of how our management team reviews and considers our operating results. By disclosing this non-GAAP measure, we believe that we create for investors a greater understanding of and an enhanced level of transparency into the means by which our management team operates our company. We also believe this measure can assist investors in comparing our performance to that of other companies on a consistent basis without regard to certain items that do not directly affect our ongoing operating performance or cash flows.

Adjusted EBITDA does not represent cash flows from operations as defined by GAAP. Adjusted EBITDA has limitations as a financial measure and you should not consider it in isolation, or as a substitute for, or superior to, financial measures calculated in accordance with GAAP. Because of these limitations, you should consider Adjusted EBITDA alongside other financial performance measures, including various cash flow metrics, net loss, gross margin, and our other GAAP results.

The following table presents a reconciliation of net (loss) income, the closest GAAP financial measure, to EBITDA and Adjusted EBITDA for each of the periods indicated:

Reconciliation of Net (Loss) Income to EBITDA and Adjusted EBITDA

    Three Months Ended June 30,   Six Months Ended June 30,
      2022       2021       2022       2021  
Net (loss) income available to common stockholders   $ (4,367 )   $ 24,776     $ (8,407 )   $ 11,926  
Interest expense, net     106       2,234       182       3,069  
Tax expense                 3        
Depreciation and amortization     430       413       839       824  
EBITDA     (3,831 )     27,423       (7,383 )     15,819  
Non-cash share-based compensation and warrant expense (a)     801       313       1,892       2,903  
Loss on disposal of assets     1       210       3       265  
Non-cash change in fair value of warrant liability and warrant derivative liability           (29,356 )           (22,873 )
Gain on extinguishment of debt, net           (851 )           (457 )
Offering relating expenses (b)           14             210  
Non-recurring strategic branding initiatives (c)     365             671        
Launch expenses (d)     480             480        
Non-recurring and other expenses (e)     50       449       185       1,305  
Adjusted EBITDA   $ (2,134 )   $ (1,798 )   $ (4,152 )   $ (2,828 )
(a) Reflects non-cash expenses related to equity compensation awards. 2021 additionally includes non-cash expenses related to stock purchase warrants issued for third-party services provided. Share-based compensation is an important part of the Company’s compensation strategy and without our equity compensation plans, it is probable that salaries and other compensation related costs would be higher.
(b) Reflects administrative costs associated with the registration of common shares and other debt and equity financing transactions.
(c) Includes one-time marketing agency and design fees for our strategic re-branding initiatives.
(d) Reflects non-recurring launch expenses related to the Elevate® launch.
(e) For the three and six months ended June 30, 2022, includes non-recurring severance costs and non-recurring professional fees. For the three months ended June 30, 2021 includes non-cash third party share-based compensation of $0.3 million and non-recurring consulting costs of $0.2 million. The six months ended June 30, 2021 additionally includes non-recurring severance costs of $0.7 million and director fees of $0.1 million, partially offset by a $0.5 million reduction to sales tax liability.

Adjusted Financial Performance Measures

The “Adjusted Financial Performance Measures” present non-GAAP financial information and should not be considered a measure of financial performance under GAAP. These measures are presented as an alternative method for assessing the Company’s operating results by adjusting for the impact of certain non-recurring, infrequent or unusual items in a manner that is focused on the performance of our underlying operations. Each of these measures are intended to provide greater consistency, comparability and clarity of our results. Management uses this non-GAAP financial information to assess the Company’s core operating results and consequently, management believes it is similarly useful information to investors.

Reconciliation of Net Sales and Gross Profit to Adjusted Net Sales and Gross Profit

    Three Months Ended June 30, 2022
    As Reported
(GAAP)
  Adjustments   As Adjusted
(Non-GAAP)
Net sales   $ 16,515     $ 480 (a) $ 16,995  
Cost of goods sold     11,788           11,788  
Gross profit   $ 4,727     $ 480   $ 5,207  
Gross profit %     29 %         31 %
(a) Reflects non-recurring launch expenses related to the Elevate® launch.
             
    Six Months Ended June 30, 2022
    As Reported
(GAAP)
  Adjustments   As Adjusted
(Non-GAAP)
Net sales   $ 33,529     $ 480 (a) $ 34,009  
Cost of goods sold     24,095           24,095  
Gross profit   $ 9,434     $ 480   $ 9,914  
Gross profit %     28 %         29 %
(a) Reflects non-recurring launch expenses related to the Elevate® launch.

About Better Choice Company Inc.
Better Choice Company Inc. is a rapidly growing pet health and wellness company focused on providing pet products and services that help dogs and cats live healthier, happier and longer lives. We offer a broad portfolio of pet health and wellness products for dogs and cats sold under our Halo brand across multiple forms, including foods, treats, toppers, dental products, chews, and supplements. We have a demonstrated, multi-decade track record of success and are well positioned to benefit from the mainstream trends of growing pet humanization and consumer focus on health and wellness. Our products consist of kibble and canned dog and cat food, freeze-dried raw dog food and treats, vegan dog food and treats, oral care products and supplements. Halo’s core products are made with high-quality, thoughtfully sourced ingredients for natural, science-based nutrition. Each innovative recipe is formulated with leading veterinary and nutrition experts to deliver optimal health. For more information, please visit https://www.betterchoicecompany.com

Forward Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The words “believe,” “may,” “estimate,” “continue,” “anticipate,” “intend,” “should,” “plan,” “could,” “target,” “potential,” “is likely,” “will,” “expect” and similar expressions, as they relate to us, are intended to identify forward-looking statements. The Company has based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our financial condition, results of operations, business strategy and financial needs. Some or all of the results anticipated by these forward-looking statements may not be achieved. Further information on the Company’s risk factors is contained in our filings with the SEC. Any forward-looking statement made by us herein speaks only as of the date on which it is made. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by law.

Company Contact:
Better Choice Company Inc.
Scott Lerner, CEO

Investor Contact:
KCSA Strategic Communications
Valter Pinto, Managing Director
T: 212-896-1254
Valter@KCSA.com

Staff

Recent Posts

Hemogenyx Pharmaceuticals PLC Announces IRB Approval for Phase I Clinical Trial

Hemogenyx Pharmaceuticals Receives IRB Approval for Phase 1 Clinical Trial of HEMO-CAR-T (HG-CT-1)LONDON, UK /…

4 hours ago

Modular Medical Announces Pricing of $8.2 Million Public Offering

SAN DIEGO, CA / ACCESSWIRE / November 21, 2024 / Modular Medical, Inc. (Nasdaq:MODD) ("Modular…

7 hours ago

Nicole Garrett and Under Pressure Hyperbarics Lead the Charge in Wellness Education With Immersive Events at L.A. Fashion Weekend and Beyond

BEVERLY HILLS, CALIFORNIA / ACCESSWIRE / November 21, 2024 / Nicole Garrett, CEO of Under…

10 hours ago

Beacon Healthcare Systems Expands Leadership Team with Addition of Ayman Mohamed as Chief Technology Officer

HUNTINGTON BEACH, Calif., Nov. 21, 2024 /PRNewswire/ -- Beacon Healthcare Systems, is pleased to announce…

13 hours ago

Talkiatry Ranked Number 6 Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500™

Attributes Revenue Growth to Innovative Partnerships, Strong Team, and Unique Value-Based Care Model NEW YORK,…

13 hours ago

Bright Light Imaging Leverages Alpha Nodus’s Gravity Auth, Enhanced by Integration with ADS’s MedicsRIS, to Streamline Patient Care

Automation That Makes a Difference SUNRISE, Fla., Nov. 21, 2024 /PRNewswire/ -- When it comes…

13 hours ago